The life sciences and healthcare industries are changing dramatically, especially in the pharmaceutical arena. With many blockbuster drugs nearing the end of patent protection, competition between branded and generic pharma companies is increasingly significant. Quality control, cost reductions, R&D investment payoff and sales force effectiveness are all vital factors in remaining competitive. SSA & Company has a broad range of strategic and operational experience in the pharmaceutical industry. We’ve been deeply involved in all fronts, including generic and branded production, discovery, distribution and sales. Our industry-leading clients include Alpharma, Merck and Charles River Laboratories, among others.

We have managed some of the most significant process initiatives in the pharmaceutical industry. For example, at one leading pharmaceutical company, we:

* Cut costs by reducing raw materials, cycle time and WIP inventory

* Boosted revenues by improving plant production efficiency, planning accuracy and customer service

* Strengthened R&D investment results, by improving the efficacy of lab operations

Within this highly technical and regulated industry, SSA & Company has a proven track record of delivering significant impact, fast.